Skip to content

Effect of whole-course nutrition management on patients with esophageal cancer undergoing concurrent chemoradiotherapy: A randomized control trial

Effect of whole-course nutrition management on patients with esophageal cancer undergoing concurrent chemoradiotherapy: A randomized control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020543
Enrollment
Unknown
Registered
2019-01-07
Start date
2017-04-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

Case series:whole-course nutrition management

Sponsors

Department of Radiotherapy, Affiliated Tumor Hospital of Zhengzhou University, He'nan Tumor Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) aged =18 years old; (2) met the indications for concurrent chemoradiotherapy (tumor stage II-III, performance status (PS) score = 2 points, karnofsky performance status (KPS) score =70 points; no signs of perforation); (3) none severe cardiovascular and cerebrovascular diseases; (4) those who are conscious and have no communication problems; (5) sign informed consent.

Exclusion criteria

Exclusion criteria: (1) patients undergoing organ transplantation or concurrent with other malignant tumors; (2) those with endocrine, metabolic diseases or other digestive diseases; (3) various liver and kidney dysfunction; (4) for intestinal or intestinal foreign nutrition preparations are allergic to any component; (5) severe malnutrition or dyscrasia.

Design outcomes

Secondary

MeasureTime frame
Quality of life evaluation;Psychological condition;short-term efficacy evaluation;

Primary

MeasureTime frame
Energy intake;energy to nitrogen ratio;Body Mass Index;Patient-Subjective Comprehensive Assessment;

Countries

China

Contacts

Public ContactLing Yuan

Department of Radiotherapy, Affiliated Tumor Hospital of Zhengzhou University, Henan Tumor Hospital

HNHNYL@126.com+86 13838027672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026